{"id":"healive-lot-3","safety":{"commonSideEffects":[{"rate":null,"effect":"Injection site pain or soreness"},{"rate":null,"effect":"Fever"},{"rate":null,"effect":"Fatigue"},{"rate":null,"effect":"Headache"}]},"_chembl":{"chemblId":"CHEMBL5853519","moleculeType":null,"molecularWeight":"319.43"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"The vaccine contains inactivated (killed) hepatitis A virus particles that trigger both humoral and cellular immune responses. This leads to the production of protective antibodies (anti-HAV IgG) and memory B cells, conferring long-term immunity against hepatitis A infection. The inactivated virus cannot cause disease but effectively primes the immune system for recognition and neutralization of wild-type virus.","oneSentence":"Healive is an inactivated hepatitis A vaccine that stimulates the immune system to produce antibodies against hepatitis A virus.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:22:46.447Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prevention of hepatitis A infection in children and adults"}]},"trialDetails":[{"nctId":"NCT00534885","phase":"PHASE4","title":"Safety, Immunogenicity, and Immune Persistence Study of an Inactivated Hepatitis A Vaccine","status":"COMPLETED","sponsor":"Sinovac Biotech Co., Ltd","startDate":"2006-03","conditions":"Hepatitis A","enrollment":400}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Healive® Lot 3","genericName":"Healive® Lot 3","companyName":"Sinovac Biotech Co., Ltd","companyId":"sinovac-biotech-co-ltd","modality":"Biologic","firstApprovalDate":"","aiSummary":"Healive is an inactivated hepatitis A vaccine that stimulates the immune system to produce antibodies against hepatitis A virus. Used for Prevention of hepatitis A infection in children and adults.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}